Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.480
-0.120 (-7.50%)
Last updated: Jun 3, 2026, 8:10 AM CET
Autolus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -288.97 | -287.53 | -220.66 | -208.38 | -141.98 | -142.1 |
Depreciation & Amortization | 10.24 | 9.81 | 7.72 | 6.57 | 7.24 | 8.46 |
Stock-Based Compensation | 15.14 | 14.44 | 15.47 | 11.2 | 13.42 | 9.94 |
Other Adjustments | 48.04 | 31.7 | 14.86 | 44.74 | -11.03 | 5.43 |
Change in Receivables | -13.46 | -24.16 | - | - | -6.45 | - |
Changes in Inventories | -32.69 | -40.25 | -4.23 | - | - | - |
Changes in Accounts Payable | -1.74 | 1.3 | 1.59 | -0.51 | 14.91 | -1.82 |
Changes in Accrued Expenses | -2.64 | 1.04 | 11.93 | 1 | - | -2.02 |
Changes in Unearned Revenue | 2.89 | - | - | - | - | - |
Changes in Other Operating Activities | 4.46 | 10.08 | -32.95 | -0.2 | - | 4.25 |
Operating Cash Flow | -273.32 | -283.57 | -206.27 | -145.59 | -103.69 | -117.86 |
Capital Expenditures | -13.49 | -19.04 | -22.08 | -10.99 | -10.87 | -8.86 |
Purchases of Intangible Assets | - | -8.09 | -12.74 | - | - | - |
Purchases of Investments | -186.04 | -242.62 | -359.73 | - | - | - |
Proceeds from Sale of Investments | 521.77 | 428.21 | - | - | - | - |
Other Investing Activities | - | - | - | - | 0.84 | - |
Investing Cash Flow | 314.16 | 158.46 | -394.55 | -10.99 | -10.04 | -8.86 |
Long-Term Debt Issued | - | - | 70 | - | 68.74 | 50 |
Long-Term Debt Repaid | - | - | - | - | -3.4 | - |
Net Long-Term Debt Issued (Repaid) | - | - | 70 | - | 65.34 | 50 |
Issuance of Common Stock | - | - | 550.58 | 0.03 | 161.23 | 246.03 |
Net Common Stock Issued (Repurchased) | - | - | 550.58 | 0.03 | 161.23 | 246.03 |
Other Financing Activities | -6.02 | -4.34 | -31.03 | -0.91 | -10.19 | -11.96 |
Financing Cash Flow | -6.4 | -4.34 | 589.55 | -0.88 | 216.38 | 284.06 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.73 | 6.28 | -0.26 | 15.03 | 2.18 | -0.75 |
Net Cash Flow | 35.17 | -123.17 | -11.53 | -142.43 | 102.65 | 156.59 |
Free Cash Flow | -286.81 | -302.61 | -228.35 | -156.57 | -114.57 | -126.72 |
FCF Margin | -309.65% | -401.41% | -2256.38% | -9221.02% | -1796.30% | -8408.63% |
Free Cash Flow Per Share | -1.08 | -1.14 | -0.89 | -0.90 | -1.21 | -1.76 |
Levered Free Cash Flow | -321.94 | -324.59 | -188.68 | -212.51 | -65.36 | -92.09 |
Unlevered Free Cash Flow | -296.15 | -305.74 | -277.76 | -183.85 | -177.61 | -141.8 |